FDA Inspection 837252 — Sharplight Technologies

Sharplight Technologies — FEI 3009352034

The FDA completed an inspection of Sharplight Technologies on June 13, 2013 in Rishon Le-Tsiyon. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 12 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 13, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Compliance: Devices
Location
Rishon Le-Tsiyon (Israel)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
1472221 CFR 820.40Procedures not adequately established or maintained
243121 CFR 820.30(b)Design plans- updated
260421 CFR 820.30(e)Design review - Lack of or inadequate procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
317121 CFR 820.198(b)Rationale documented for no investigation
328521 CFR 820.90(b)(2)Product rework procedures, Lack of or inadequate procedures
334321 CFR 820.198(e)Maintained
503221 CFR 1010.2(b)Certification label or tag
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.